The first quarter of 2026 has witnessed the operationalization of in-situ bioprinting across several European surgical centers, marking a departure from traditional "lab-to-clinic" delays. These systems allow surgeons to deposit bio-inks directly into a patient’s wound or surgical site during a procedure, significantly improving healing times for complex soft-tissue injuries. This...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt